A phase 2b study evaluating repibresib gel in nonsegmental vitiligo did not meet its primary endpoint and an ongoing ...

V Foundation for Cancer Research has named Diana Hargreaves, PhD, a 2025 All-Star Translational Award Program grantee, ...

Alcon launched Tryptyr, a treatment for the signs and symptoms of dry eye disease, in the U.S. Tryptyr (acoltremon ophthalmic solution 0.003%) is a TRPM8 receptor agonist that showed a “statistically ...